Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling Nature Cancer - Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin...

Let's start the 2025 with a blast 🎇. Out today on @naturecancer.bsky.social Würth et al., on HER3/NRG1 and FGFR1 compensatory mechanism in CTCs and how to hijack that for long term in vitro culture.
#CTC #breastcancer #liquidbiopsies #NGS #personalizedmedicine @dkfz.bsky.social #HISTEM
rdcu.be/d5pGe

Deadline coming close for PhD position on 20C French philosophy of science and technology at @fasosmaastricht.bsky.social #philsci #philtech #histem

Citizen science in action #GreatNature #HIStem http://instagram.com/p/njedCITV6n/